Editorial: RNA recognition landscapes and anticancer drug targeting

Frontiers in Oncology

Oncology

Maciej Wnuk¹  Anna Lewinska¹  Erica Salvati²  Vito G. D’Agostino³  Erik Dassi⁴ 

[1] Institute of Biotechnology, College of Natural Sciences, University of Rzeszow, Rzeszow, Poland;Institute of Molecular Biology and Pathology, National Research Council, Rome, Italy;Laboratory of Biotechnology and Nanomedicine, Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, Trento, Italy;Laboratory of RNA Regulatory Networks, Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, Trento, Italy;

关键词: RNA;    RNA-binding proteins;    post-transcriptional control;    drug;    mechanism of action (MOA);    anti-cancer;    anti-inflammatory;   

DOI  :  10.3389/fonc.2023.1222883

 received in 2023-05-15, accepted in 2023-05-30,  发布年份 2023

来源: Frontiers

【 授权许可】

Unknown   
Copyright © 2023 Salvati, Lewinska, Dassi, Wnuk and D’Agostino